
Chemical and Pharmaceutical Bulletin p. 1314 - 1317 (2005)
Update date:2022-08-04
Topics: Antagonists Mechanism-Based Inhibition Nonpeptide Minimization CYP3A4
Hashimoto, Kentaro
Kataoka, Mikayo
Tatsuta, Miyuki
Yasoshima, Kayo
Yamamoto, Mako
Yura, Takeshi
Yamamoto, Noriyuki
Urbahns, Klaus
Gupta, Jang Bahadur
Yingfu
Herein we report the development of novel, potent and non-peptide luteinizing hormone releasing hormone (LHRH) antagonists. The optimization towards derivatives free from mechanism-based CYP3A4 inhibition is described. The identification of a main metabol
View MoreShanghai Longjin Metallic Material Co., Ltd.
website:http://www.shlongjin.cn/
Contact:021-56517503,56502257
Address:No.16, Lane 555, Chengyin Road, Shanghai
Shanghai Hanhong Scientific Co.,Ltd.
website:http://www.chemvia.com
Contact:+86-21-64541543,54280654,13918533501
Address:Jiachuan Road 245
Shanghai better-in Medical Technology Co.,LTD.
Contact:+86-21-38921049
Address:Lane 720 zhangjianggaoke cailun road, Pudong, Shanghai, room 513
JiangXi Hong Run Chemical Co., Ltd
Contact:+86-0791-88521351
Address:XingHuo industrial zone in YongXiu county
Nanjing Spring & Autumn Biological Engineering Co., Ltd.
Contact:86-180510-83338
Address:Suite# 210, No. 1 BuildingNanjing Agricultural Biotechnology High-tech Entrepreneurship Center, No. 4 Tongwei Road, Xuanwu District, Nanjing,China
Doi:10.1021/ol006191s
(2000)Doi:10.1039/jr9490000615
(1949)Doi:10.1021/jo00359a061
(1986)Doi:10.1021/jp010058f
(2001)Doi:10.1016/S0040-4039(98)01176-9
(1998)Doi:10.1021/jm401387j
(2013)